Healthcare & Life Sciences
Serpin Pharma
United Statesserpinpharma.com
Serpin Pharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
series-c-plus
series-c-plus
Stage
2
Investors
About Serpin Pharma
Serpin Pharma is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Serpin Pharma develops peptide-based therapeutics targeting the LRP1 receptor to modulate immune response and reduce inflammation, with a lead compound SP16 under development for acute myocardial infarction and other inflammatory conditions.
Explore Serpin Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.